Warning! GuruFocus detected
5 Severe warning signs
with 52X.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Magle Chemoswed Holding AB
ISIN : SE0014401014
Share Class Description:
STU:52X: Ordinary SharesCompare
Compare
Traded in other countries / regions
MAGLE.Sweden52X.Germany IPO Date
2020-07-07Description
Magle Chemoswed Holding AB is a contract development and manufacturing organization that serves companies in the pharmaceutical and medical device industry on a contract basis. It provides comprehensive services from product development through product manufacturing. The company's products portfolio includes Warfarin sodium, Melperone hydrochloride, Isradipine, Amantadine sulfate, and Benserazide hydrochloride.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.04 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.43 | |||||
| Debt-to-EBITDA | 4.29 | |||||
| Interest Coverage | 2.33 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.21 | |||||
| Beneish M-Score | -1.41 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -5.5 | |||||
| 3-Year EBITDA Growth Rate | 14.1 | |||||
| 3-Year EPS without NRI Growth Rate | 61.9 | |||||
| 3-Year Book Growth Rate | 8.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 6.64 | |||||
| 9-Day RSI | 13.94 | |||||
| 14-Day RSI | 20.88 | |||||
| 3-1 Month Momentum % | -8.39 | |||||
| 6-1 Month Momentum % | -12.26 | |||||
| 12-1 Month Momentum % | 1.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.97 | |||||
| Quick Ratio | 0.49 | |||||
| Cash Ratio | 0.03 | |||||
| Days Inventory | 783.89 | |||||
| Days Sales Outstanding | 38.88 | |||||
| Days Payable | 364.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.6 | |||||
| Shareholder Yield % | -9.06 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 88.98 | |||||
| Operating Margin % | 7.22 | |||||
| Net Margin % | 8.12 | |||||
| FCF Margin % | 6.33 | |||||
| ROE % | 7.47 | |||||
| ROA % | 4.19 | |||||
| ROIC % | 3.6 | |||||
| 3-Year ROIIC % | 15.75 | |||||
| ROC (Joel Greenblatt) % | 12.31 | |||||
| ROCE % | 8.57 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 16.66 | |||||
| PE Ratio without NRI | 48.73 | |||||
| PEG Ratio | 1.47 | |||||
| PS Ratio | 1.34 | |||||
| PB Ratio | 0.58 | |||||
| Price-to-Tangible-Book | 0.72 | |||||
| Price-to-Free-Cash-Flow | 21.27 | |||||
| Price-to-Operating-Cash-Flow | 21.27 | |||||
| EV-to-EBIT | 28.8 | |||||
| EV-to-EBITDA | 15.15 | |||||
| EV-to-Revenue | 3.56 | |||||
| EV-to-FCF | 56.88 | |||||
| Price-to-GF-Value | 0.63 | |||||
| Price-to-Graham-Number | 1.23 | |||||
| Earnings Yield (Greenblatt) % | 3.48 | |||||
| FCF Yield % | 2.42 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Magle Chemoswed Holding AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 18.272 | ||
| EPS (TTM) (€) | 0.137 | ||
| Beta | 0.77 | ||
| 3-Year Sharpe Ratio | 0.19 | ||
| 3-Year Sortino Ratio | 0.31 | ||
| Volatility % | 42.75 | ||
| 14-Day RSI | 20.88 | ||
| 14-Day ATR (€) | 0.059681 | ||
| 20-Day SMA (€) | 2.681 | ||
| 12-1 Month Momentum % | 1.53 | ||
| 52-Week Range (€) | 2.2 - 3.936225 | ||
| Shares Outstanding (Mil) | 20.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Magle Chemoswed Holding AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Magle Chemoswed Holding AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Magle Chemoswed Holding AB Frequently Asked Questions
What is Magle Chemoswed Holding AB(STU:52X)'s stock price today?
The current price of STU:52X is €2.24. The 52 week high of STU:52X is €3.94 and 52 week low is €2.20.
When is next earnings date of Magle Chemoswed Holding AB(STU:52X)?
The next earnings date of Magle Chemoswed Holding AB(STU:52X) is 2025-04-18 Est..
Does Magle Chemoswed Holding AB(STU:52X) pay dividends? If so, how much?
Magle Chemoswed Holding AB(STU:52X) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers